Amolab
我们是谁？
Amolab is an innovative SME, founded in Lecce in 2011 as a spin-off of the National Research Council and specialises in the research, development, design and production of revolutionary ultrasound devices for diagnostic imaging. Its vocation for researching new solutions is confirmed by its registration in the special section of the Innovative Companies Register. The company has several patents for industrial inventions in the field of medical devices to its credit and is rapidly expanding commercially in all continents.
Amolab has brought to the market the first and only technological solution for both the safe, automatic and quantitative monitoring of the progression of childbirth and the rapid and non-invasive investigation of lung health, eliminating operator dependence and reducing the possibility of human error. The system developed is based on a patented technology (National Research Council Patent No. EP2375980) and unique in the world, which integrates quantitative ultrasound hardware and software (QUS) in an advanced system that overcomes the limitations of traditional ultrasound due essentially to qualitative and operator-dependent assessments.
我们的价值观
MISSION:
Amolab's mission is to put science at the service of society for the development of non-invasive solutions aimed at improving the quality of life and making the world's healthcare system more effective and more sustainable; it is also to provide the world's medical community with the first technological and non-invasive solution for the safe, automatic and non-invasive monitoring of both labour labour and lung health. Amolab offers physicians an objective and reliable tool to both assess fetal well-being during the transition from intrauterine to extrauterine life and to detect multiple lung diseases.
1. The first technological solution for safe, automatic and non-invasive monitoring of labour and offers an objective and reliable tool to assess fetal well-being during the transition from intrauterine to extrauterine life.
2. Automated and non-invasive diagnosis of lung disease using a rapid, fully automatic, radiation-free and highly reliable examination to provide clinicians with an immediate solution for the personalised management of patients with lung disease.
